Stock listing

Spero Therapeutics, Inc.

Selected listing: A2H63F · LS · EUR · DE

Spero Therapeutics, Inc. (Lang & Schwarz: A2H63F), Health Technology. Latest release Oct 2, 2026: Spero Therapeutics Announces Inducement Grants Under Nasdaq…

A2H63F:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2H63F
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Spero Therapeutics, Inc.

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 2, 2026

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 1, 2026

Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

September 2, 2026

Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update

August 12, 2026

Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

August 4, 2026

All Spero Therapeutics, Inc. news →

Events

Replays

Spero Therapeutics, Inc. (SPRO) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 05:00 PM ET
Watch
Spero Therapeutics, Inc. (SPRO) Q2 2025 Earnings Call
Tue, Aug 12, 2025 · 04:30 PM ET
Watch
Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call
Thu, Mar 27, 2025 · 04:30 PM ET
Watch

Research Spero Therapeutics, Inc.

Spero Therapeutics, Inc. company profile

View the public company page for Spero Therapeutics, Inc. on 6ix.

Spero Therapeutics, Inc. news

Read company news and market updates connected to Spero Therapeutics, Inc..

Spero Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Spero Therapeutics, Inc..